Preclinical study of a recombinant soluble tumor necrosis factor receptor: effect on immune response of renal allograft recipients.
Wee
S
S
Transplantation Unit, Massachusetts General Hospital, Boston.
Boskovic
S
S
Eason
J D
JD
Widmer
M B
MB
Benedict Cosimi
A
A
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008252:Macaca fascicularis; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D016572:Cyclosporine